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Despite the development of powerful molecular biological techniques and technologies, studies involving 
research animals remain a key component of discovery biology, and in the discovery and development of 
new medicines. In 1959, The Principles of Humane Experimental Technique, the 3Rs 
(Replacement, Reduction and Refinement) were developed to provide a framework to ensure animal 
research was undertaken as humanely as possible.  Sixty years since their inception, the extent to which the 
3Rs have been adopted and implemented by the global scientific and medical research communities has 
unfortunately been slow and patchy.  However, this situation is changing rapidly as awareness increases, not 
only of the 3Rs themselves, but of the impact of animal welfare on the reproducibility, reliability and 




The earliest records of the use of animals for scientific and medical research are from the 4th and 3rd 
centuries BC.  Since then, the number of animals used for research worldwide has progressively increased, 
particularly in the 18th and 19th centuries, a consequence of the dramatic increase in scientific endeavours 
during this period.  Despite the development of powerful molecular biological techniques and technologies, 
rightly or wrongly, studies involving research animals, undertaken in parallel with complimentary, non-animal 
experimental approaches, remain a key component of discovery biology, and in the discovery and 
development of new medicines.  
Animal experiments, by their very nature and purpose, will cause pain, suffering and distress, and in many 
cases, the death, of the research animal. Morally and ethically, it is critical to minimise these harms, to 
undertake these studies as humanely as possible, in short, to apply The Principles of Humane Experimental 
Technique, the 3Rs, first articulated by Russell and Birch in 1959 [1].  Sixty years on, this article does not 
seek to argue for or against the use of animals for research. Instead, to reflect on the extent to which these 
Principles have been adopted, applied and developed by the global research community.   
 
What are the Principles of Humane Experimental Technique, the 3Rs? [2] 
 Replacement:  Methods which replace the use of animals in research.  These may be absolute i.e. 
no use of animals or animal tissues at all (e.g. studies involving human participants, computer 
simulations), or partial, the use of tissues or cells from humanely killed animals. In some 
jurisdictions, for example the European Union,, replacement could include replacement of protected 
species with non-protected species (e.g. immature vertebrates or invertebrates). 
 Refinement: Methods which minimise the pain, suffering or distress of the research animal (e.g. 
administration of analgesics and anaesthetics, housing animals in social groups with appropriate 
enrichment of their environments to allow them to express natural behaviours, monitoring of welfare 
before, during and after experiments). 
 Reduction: minimising the number of animals required per study (e.g. making multiple 
measurements, and at multiple time points, from the same animal), whilst maintaining robust 
experimental design to enable appropriate statistical analysis of the data.  Alternatively, power 
calculations to calculate the optimal number of animals required, although this does require pilot data 
or access to data from previous studies. 
 
Since their introduction, additional Rs have emerged globally.  The “Reuse” of individual animals in further 
studies where these studies cause no additional suffering for the animal, the “Rehabilitation” or aftercare of 
the research animal, a legal requirement in India, and in South Africa, the requirement to demonstrate 
“Respect” for the animal.  There is also Relevance, the need to use a specific species if, for example, you 
wish to explore that particular species’ physiology, behaviour or neurobiology, or for the purpose of 
conservation biology, where replacement with less sentient species, cells or computer modelling approaches 
would not allow you to address these scientific questions [3]. 
 
Which R should take precedence? 
Without question, the Replacement of animals with non-animal alternatives has to be the ultimate goal of all 
those involved in animal experimentation.  Any other position is morally indefensible. Whilst considerable 
resources are being devoted to the development and validation of non-animal alternatives, unfortunately 
there are still many scientific questions that can only be answered using research animals. If there is no 
alternative to animal use, opinions on whether Refinement or Reduction takes precedence vary.  In some 
countries, particularly in the Emerging World, Reduction comes before Refinement, a consequence of limited 
resources and pressure from ill-advised ethical review bodies [4,5], personal communications]. The result: 
studies that are underpowered, with insufficient numbers of animals used to enable appropriate statistical 
analysis of the data obtained to be undertaken.  The data obtained is meaningless and the animals have 
suffered and/or died needlessly. We are the voice of the research animal; we should consider it from the 
perspective of an individual animal, and their individual, specific suffering.  For me there is no debate, 
Refinement has to take precedence over Reduction. If suffering is unavoidable, it is preferable to cause 
limited suffering to a number of animals rather than a large amount of suffering to an individual animal. 
Further, multiple small refinements, for example how animals are housed, handled, the presence of 
stimulatory environments/objects in their enclosure, when provided together, can have a considerable, 
cumulative impact in reducing animal suffering and distress. 
 
Adoption of the 3Rs globally 
Sixty years on since they were first articulated, the extent to which the 3Rs have been adopted and 
implemented by the global scientific and medical research communities has unfortunately been slow and, at 
best, patchy or varied, both across continents and between research areas.   
Globally, until the publication of the book “Alternatives to Animal Experiments” in 1978 [6], there was very 
limited awareness and therefore adoption of these Principles.  With significant investment in the 
development and validation of alternatives, particularly by global Pharma, the creation of national 3Rs 
Centres, and legislative changes, the situation is changing, particularly in Europe. Elsewhere in the World, 
progress is less forthcoming. There is still a considerable amount of work to be undertaken, both in raising 
awareness in those countries where knowledge of the 3Rs is currently limited, and in promoting their 
adoption and application by the entire global research community. 
Critical to this is the enshrinement within robust ethical review processes and in law, and the establishment 
of national 3Rs initiatives and centres.  Many countries do not have research animal welfare legislation, 
animal ethics committees (Institutional Animal Care and Use Committees) or indeed a legal requirement for 
the ethical review of animal studies [7]. Research, including animal research, is a global endeavour.  There 
needs to be greater harmonisation, globally, of research animal welfare legislation and ethical review 
processes similar to that that exists for human clinical trials.  There also needs to be a mandatory, legally 
enforced focus on the application of the 3Rs for all animal studies.   
 
Adoption and application of each R 
Replacement: There has been some notable recent successes in the development of non-animal 
alternatives, for example the development of “Organ on a Chip” technologies and the widespread use of 
databases for the toxicological evaluation of potential new medicines.  Indeed, the UK Governments strategy 
is to become the world leader in the development of alternatives over the next 25 years [8]. However, despite 
the considerable effort and resource being devoted globally to the development of alternatives, there is 
considerable reluctance amongst the research community to adopt them, the so called “3Rs valley of Death”- 
development but limited uptake or use.  The reasons for this lack of uptake could be many: a lack of 
awareness amongst the research community; an unwillingness to let go of, or acknowledge, the limitations of 
animals preparations/techniques on which they have published extensively; limited published historical or 
background data from these alternatives; minimal external pressure to change.  Driving forward replacement 
is going to take a concerted and more forceful effort from all involved; Ethical review bodies, funders, 
regulatory authorities, journals, raising awareness but also refusing to fund, approve or publish studies 
involving animals unless the researcher fully justifies why animals have to be used. 
Our goal is to replace animals but with what?  Replacement of vertebrates with non-animal alternatives, for 
example, computer simulations and ethically sourced human cell cultures, does not raise additional ethical 
issues, but what about with animals of lower sentience, those thought to be less able to perceive pain e.g. 
flies, insects, worms?  Most jurisdictions that place restrictions on species require the use of the species of 
lowest sentience provided it is capable of addressing the scientific question under investigation [7]. However, 
it is becoming increasing apparent that invertebrates, particularly insects, exhibit aversive responses that do 
not meet our current “criteria” for a response to painful stimuli [9,10].  Is it morally justifiable to provide 
protection for one species but not another? Should we treat all living creatures equally? In India, animal 
welfare legislation provides protection for all living beings, including insects, except man. 
 
Refinement: There is an increasing realisation that animal welfare, the minimising of pain suffering and 
distress, can have a substantial impact on the reproducibility and reliability of the data obtained [11]. The 
data from the majority of pre-clinical animal studies is not reproducible in humans [12].  Morally, should we 
continue with such studies if the data obtained cannot be trusted?   
Until recently, it was believed that standardisation of everything was the answer. However, it is becoming 
increasing apparent that this is not the case; housing, environment, handling, diet, gut microbiome and many 
other factors can have a substantial impact on the data obtained, and its reproducibility [13,14].  Animals, like 
humans, are a heterogeneous population, living beings rather than research tools; we should view them as 
such if we want to increase the validity of animal studies.  We also need to adopt many of the practices 
involved in clinical research: randomisation of studies, double blinding, multicentre studies, minimisation of 
bias and robust experimental design [15].  Without these interventions, data is only reproducible in the 
laboratory in which it was gathered at that particular moment in time.   
There is a need to raise awareness in the research community of all the known factors that could influence 
the reproducibility and reliability of their data, for research into the impact of each intervention on 
experimental outcomes, and greater communication and collaboration between researchers and animal 
welfare experts, and the sharing and promotion of each other’s 3Rs resources. Increased use of 
PREPARE guidelines [16] in designing studies, and a requirement to fully detail, as per the ARRIVE [17] or 
similar guidelines, all welfare interventions in publications.  Researchers should treat with caution and 
question the validity of any data where the 3Rs have not been applied or fully described.  
Current initiatives, led by animal welfare organisations, to abolish studies that cause severe suffering to 
animals [18] or the use of procedures, such as the forced swim test [19,20], which have questionable validity 
or translatability to human disorders should be encouraged and implemented. Similarly, there should be 
more non-regulatory expert working groups working collaboratively to develop recommendations to refine 
existing animal models or procedures in specific areas of research, for example animal models of sepsis and 
septic shock [21], in order to reduce animal use and suffering, 
. 
Reduction: The number of animals used for scientific and medical research worldwide is unknown; most 
countries do not keep records.  Animal activist organisations estimate that over 100 million animals may be 
used worldwide every year.  Because of the lack of records, nobody knows whether this figure is increasing 
or decreasing, whether researchers are implementing principle of Reduction. 
In the UK, one of the few countries to collate and publish the numbers of research animals used annually 
within its jurisdiction, from the late 1930s to the present day, the numbers have cycled between 1 million and 
5.5 million [22].  Whilst the number of wild-type or non-genetically altered animals is falling, which is to be 
encouraged, the total number of procedures on animals in the UK has increased over the last 15 years, 
plateauing at the current level of approximately 4 million per year [22].  This increase in numbers is due to 
the creation, breeding but not necessarily use of genetically altered animals or animals with a harmful 
spontaneous genetic mutation, the number of wild-type animals used is falling [22].  Genetically altered 
animals, which are bred but not used, are included as procedures in both UK and EU statistical reports.  In 
addition to running counter to the principal of reduction, this increased creation, breeding and use of 
genetically altered animals raises other significant ethical issues - the excessive wastage of animals, the 
increased likelihood of them experiencing suffering including severe suffering, whether they are accurate 
models of human disease to name but a few. 
  
The way forward 
Whilst the 3Rs are increasingly being implemented by the global research community, for the sake of the 
research animals and the validity of the ensuing data, there needs to be far greater momentum and impetus.  
There has to be far greater raising of awareness, globally, of the 3Rs and their impact, mandatory education, 
training and continuing professional development, and increased collaboration between all involved- 
students, early career and established researchers, vets, animal caretakers and technologists, animal 
welfare experts and animal ethics committee members.  There needs to be more funding for 3Rs 
interventions, greater sharing and promotion of 3Rs resources including those developed by other agencies 
or bodies, the global harmonisation of animal welfare legislation and the strengthening of ethical review 
processes.  Collectively, we should all be striving to go beyond what is legally required, developing and 
fostering a “Culture of Care” [23,24], a commitment to improving animal welfare, scientific quality, care of 
staff and transparency for stakeholders, within our organisations and practices when animals have to be 
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